Bionano Genomics, Inc. (BNGO) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Bionano Genomics, Inc. (NASDAQ:BNGO) is held by 30 institutional firms.

• The percentage of Bionano Genomics owned by institutions changed from 8.1% in September 2025 to 29.5% in December 2025, marking a slight up trend.
• On a quarter-over-quarter basis, institutional holdings shifted by 347.48%, with a year-over-year a decrease of 43.40% in the count of filers.
• Among the 30 institutional holders of Bionano Genomics, 14 added to their stakes while 8 trimmed their positions and 8 held steady.
• The total number of shares held by institutions in Bionano Genomics increased to 885.16K as of December 2025, a net change of up by 687.35K shares quarter on quarter, and down 5.22Mn shares year over year.
• The top institutional stake in Bionano Genomics as of December 31, 2025 belongs to GSA CAPITAL PARTNERS LLP, which owns 337.78K shares, or 11.26% of the company.
• Among the most significant buyers of Bionano Genomics during December 2025 were GSA CAPITAL PARTNERS LLP (337.78K), DRW Securities, LLC (168.45K), TWO SIGMA INVESTMENTS, LP (40.51K), GEODE CAPITAL MANAGEMENT, LLC (39.93K), RENAISSANCE TECHNOLOGIES LLC (37.00K).
• Leading sellers of Bionano Genomics stock in December 2025 included UBS Group AG (54.82K), MORGAN STANLEY (3.98K), WELLS FARGO & COMPANY/MN (83), BANK OF AMERICA CORP /DE/ (54), GROUP ONE TRADING LLC (46).
• The top 10 institutional holders of Bionano Genomics for the quarter ending December 2025 included GSA CAPITAL PARTNERS LLP (337.78K), DRW Securities, LLC (168.45K), VANGUARD GROUP INC (82.31K), GEODE CAPITAL MANAGEMENT, LLC (66.77K), CARRET ASSET MANAGEMENT, LLC (44.10K), TWO SIGMA INVESTMENTS, LP (40.51K), RENAISSANCE TECHNOLOGIES LLC (37.00K), JANE STREET GROUP, LLC (22.17K), NORTHERN TRUST CORP (20.52K), R Squared Ltd (13.77K).